During the past decade, Croatia - managed by CRO conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Croatia - managed by CRO" are "Deep Vein Thrombosis" (1 trials) and "Psoriasis Vulgaris" (1 trials). Many other conditions were trialed in "Croatia - managed by CRO" in a lesser frequency.

Most popular intervention types in "Croatia - managed by CRO" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Calcipotriol" (1 trials), "Calcipotriol plus hydrocortisone (LEO 80190)" (1 trials), "Heparin" (1 trials), "Hydrocortisone" (1 trials) and "LEO 80190 Vehicle" (1 trials). Other intervention names were less common.

The vast majority of trials in "Croatia - managed by CRO" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Croatia - managed by CRO". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Croatia - managed by CRO, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Croatia - managed by CRO, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".